News Releases News Releases Year None20212020201920182016 Jun, 10 2021 TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting Jun, 8 2021 TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021) May, 4 2021 TransMedics Reports First Quarter 2021 Financial Results Apr, 20 2021 TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021 Apr, 6 2021 TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System Apr, 6 2021 TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System Mar, 24 2021 TransMedics Appoints Stephanie Lovell to Board of Directors Mar, 2 2021 TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results Mar, 1 2021 TransMedics Announces Scheduling of OCS Heart FDA Advisory Committee Meeting Feb, 16 2021 TransMedics to Present at the Cowen 41st Annual Healthcare Conference Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 11
News Releases Year None20212020201920182016 Jun, 10 2021 TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting Jun, 8 2021 TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021) May, 4 2021 TransMedics Reports First Quarter 2021 Financial Results Apr, 20 2021 TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021 Apr, 6 2021 TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System Apr, 6 2021 TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System Mar, 24 2021 TransMedics Appoints Stephanie Lovell to Board of Directors Mar, 2 2021 TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results Mar, 1 2021 TransMedics Announces Scheduling of OCS Heart FDA Advisory Committee Meeting Feb, 16 2021 TransMedics to Present at the Cowen 41st Annual Healthcare Conference Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 11
Jun, 8 2021 TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021)
Apr, 6 2021 TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System
